Alcoholic Neuropathy Medication
- Author: Scott R Laker, MD; Chief Editor: Robert H Meier, III, MD more...
Painful dysesthesias associated with alcoholic neuropathy can be treated using gabapentin or amitriptyline as adjunct agents with other OTC pain medications, such as aspirin or acetaminophen.
Use of certain antiepileptic drugs, such as the gamma aminobutyric acid (GABA) analogue gabapentin (Neurontin), has proven helpful in some cases of neuropathic pain. These drugs have central and peripheral anticholinergic effects, as well as sedative effects, and they block the active reuptake of norepinephrine and serotonin. The multifactorial mechanism of analgesia could include improved sleep, an altered perception of pain, and an increase in the pain threshold. Rarely should these drugs be used in the treatment of acute pain, because a few weeks may be required for them to become effective.
Gabapentin has anticonvulsant properties and antineuralgic effects; however, the exact mechanism of action is unknown. Gabapentin is structurally related to GABA but does not interact with GABA receptors.
These agents make up a complex group of drugs that have central and peripheral anticholinergic effects, as well as sedative effects. They have central effects on pain transmission and block the active reuptake of norepinephrine and serotonin.
Amitriptyline is an analgesic for certain chronic and neuropathic pain.
When used topically, capsaicin works through the depletion of substance P. It causes significant burning sensations when applied, and patients must be educated about this effect.
Capsaicin is a natural chemical derived from plants of the Solanaceae family. It penetrates deep for temporary relief of minor aches and pains of muscles and joints associated inflammatory reactions. It may render skin and joints insensitive to pain by depleting substance P in peripheral sensory neurons.
Yerdelen D, Koc F, Uysal H. Strength-duration properties of sensory and motor axons in alcoholic polyneuropathy. Neurol Res. 2008 Sep. 30(7):746-50. [Medline].
Corsetti G, Rezzani R, Rodella L, Bianchi R. Ultrastructural study of the alterations in spinal ganglion cells of rats chronically fed on ethanol. Ultrastruct Pathol. 1998 Jul-Aug. 22(4):309-19. [Medline].
Narita M, Miyoshi K, Narita M, Suzuki T. Involvement of microglia in the ethanol-induced neuropathic pain-like state in the rat. Neurosci Lett. 2007 Feb 27. 414(1):21-5. [Medline].
Miyoshi K, Narita M, Takatsu M, Suzuki T. mGlu5 receptor and protein kinase C implicated in the development and induction of neuropathic pain following chronic ethanol consumption. Eur J Pharmacol. 2007 May 21. 562(3):208-11. [Medline].
McDonough KH. Antioxidant nutrients and alcohol. Toxicology. 2003 Jul 15. 189(1-2):89-97. [Medline].
Montoliu C, Valles S, Renau-Piqueras J, Guerri C. Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: effect of chronic alcohol consumption. J Neurochem. 1994 Nov. 63(5):1855-62. [Medline].
Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Therapeutic role of curcumin in prevention of biochemical and behavioral aberration induced by alcoholic neuropathy in laboratory animals. Neurosci Lett. 2012 Mar 5. 511(1):18-22. [Medline].
Tiwari V, Kuhad A, Chopra K. Neuroprotective effect of vitamin E isoforms against chronic alcohol-induced peripheral neurotoxicity: possible involvement of oxidative-nitrodative stress. Phytother Res. 2012 Nov. 26(11):1738-45. [Medline].
Nguyen VA, Le T, Tong M, Mellion M, Gilchrist J, de la Monte SM. Experimental alcohol-related peripheral neuropathy: role of insulin/IGF resistance. Nutrients. 2012 Aug. 4(8):1042-57. [Medline].
Koike H, Iijima M, Sugiura M, et al. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol. 2003 Jul. 54(1):19-29. [Medline].
Koike H, Mori K, Misu K, et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology. 2001 Jun 26. 56(12):1727-32. [Medline].
Masaki T, Mochizuki H, Matsushita S, Yokoyama A, Kamakura K, Higuchi S. Association of aldehyde dehydrogenase-2 polymorphism with alcoholic polyneuropathy in humans. Neurosci Lett. 2004 Jun 17. 363(3):288-90. [Medline].
Michalak S, Michalowska-Wender G, Adamcewicz G, et al. Erythrocyte transketolase activity in patients with diabetic and alcoholic neuropathies. Folia Neuropathol. 2013. 51(3):222-6. [Medline].
Avaria Mde L, Mills JL, Kleinsteuber K, et al. Peripheral nerve conduction abnormalities in children exposed to alcohol in utero. J Pediatr. 2004 Mar. 144(3):338-43. [Medline].
Pessione F, Gerchstein JL, Rueff B. Parental history of alcoholism: a risk factor for alcohol-related peripheral neuropathies. Alcohol Alcohol. 1995 Nov. 30(6):749-54. [Medline].
Ammendola A, Gemini D, Iannaccone S, et al. Gender and peripheral neuropathy in chronic alcoholism: a clinical-electroneurographic study. Alcohol Alcohol. 2000 Jul-Aug. 35(4):368-71. [Medline].
Peters TJ, Kotowicz J, Nyka W, et al. Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial. Alcohol Alcohol. 2006 Nov-Dec. 41(6):636-42. [Medline].
Fama R, Eisen JC, Rosenbloom MJ, et al. Upper and lower limb motor impairments in alcoholism, HIV infection, and their comorbidity. Alcohol Clin Exp Res. 2007 Jun. 31(6):1038-44. [Medline].
Robinson-Papp J, Gelman BB, Grant I, Singer E, Gensler G, Morgello S. Substance abuse increases the risk of neuropathy in an HIV-infected cohort. Muscle Nerve. 2012 Apr. 45(4):471-6. [Medline].
Schott K, Schafer G, Günthner A, Bartels M, Mann K. T-wave response: a sensitive test for latent alcoholic polyneuropathy. Addict Biol. 2002 Jul. 7(3):315-9. [Medline].
Gane E, Bergman R, Hutchinson D. Resolution of alcoholic neuropathy following liver transplantation. Liver Transpl. 2004 Dec. 10(12):1545-8. [Medline].
Laycock MA. Drug-induced peripheral neuropathies. Biller J editor. Iatrogenic neurology. Butterworth-Heinemann: Boston; 1998. 19(5): 269-82.
Dell PC, Guzewicz RM. Atypical peripheral neuropathies. Hand Clin. 1992 May. 8(2):275-83. [Medline].